HOME - Companies - News
 
 
23 September 2025

Henry Schein Authorizes $750 Million Stock Buyback


Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care products and services to office-based dental and medical practitioners, announced today that its board of directors has authorized the repurchase of up to $750 million of shares of the company’s common stock.

This program is in addition to the $500 million repurchase program announced in January 2025, which is anticipated to be fully executed by the end of the first quarter of 2026.

The company had approximately 118.6 million shares outstanding as of September 8, 2025. This new authorization represents approximately 9.0 percent of shares outstanding at the current stock price. Purchases may be made from time to time in the open market or through negotiated transactions.

“Henry Schein’s decision to repurchase shares reflects the confidence we have in our 2025–2027 BOLD+1 strategic plan and its potential to deliver sustainable growth and value,” said Ronald N. South, senior vice president and chief financial officer. “With the support of a strong balance sheet, we are well positioned to serve our markets and further expand the depth and reach of our health care solutions.”

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.

Our business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A Fortune 500 company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The company’s sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.


Source: www.henryschein.com

Related articles

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...


The newest addition to Henry Schein’s Maxima family of performance handpieces, the MA100 was built on the same technology that is used in the Maxima Advanced Ultrasonic Cleaner MA210—the 2-gallon...


A total digital sensor solution, the Carina Digital Intraoral Sensor from Henry Schein offers simplicity and versatility with 2 sizes for patient comfort.


Henry Schein Orthodontics has introduced Aria Expressions Champagne Gold brackets, now available in a refined new shade designed to help orthodontic practices stand out. 


Henry Schein Dental confirms its presence at the British Dental Industry Association’s (BDIA) Dental Showcase, that will take place in London from 13 to 14 March 2026. Henry Schein’s stand number...


Read more

The Vertical Dimension in Prosthetis and Orthognathodontics - Edra Publishing book cover

The Vertical Dimension in Prosthetis and Orthognathodontics is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.


For 40 years, our editorial team has had the privilege of identifying and showcasing the products, technologies, materials, and solutions making a real impact across the dental pro


DS World Las Vegas is just around the corner—September 24 to September 26 at the MGM Grand


(6699.HK) (“Angel”) http://www.angelaligner.com said recently that it will appeal the August 10 first-instance judgment by the Jinan Intermediate People’s Court (Jinan City, China)


From collaborative research to exceptional patient care and education , 2025 was a year of innovation and impact at the University of Colorado Anschutz School of Dental Medicine.


 
 
 
 

 
 
 
 

Most popular

 
 

Events